Saying this is bad is the epitome of not being able to see the forest through the trees. In this update an analyst is forecasting close to 2 billion dollars a year in peak sales (based on only 2 of its drugs)for ariad which is currently valued at or slightly below 2 billion dollars. The analyst also puts a price target of 15 on it while we are currently priced at sub 9. If this is bad news, as an ariad investor, I'll take this kind of bad news everyday.
Register for free to join our community of investors and share your ideas. You will also get access to streaming quotes, interactive charts, trades, portfolio, live options flow and more tools.